BamSEC and AlphaSense Join Forces
Learn More

Humacyte Inc.

NASDAQ: HUMA    
Share price (12/23/24): $4.65    
Market cap (12/23/24): $585 million

Material Contracts Filter

EX-10.1
from 8-K 30 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 11 pages Humacyte, Inc. 5,681,820 Shares of Common Stock Warrants to Purchase Up to 5,681,820 Shares of Common Stock Placement Agent Agreement
12/34/56
EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 38 pages Purchase Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Waiver and Amendment to Revenue Interest Purchase Agreement May 8, 2024
12/34/56
EX-10.1 2
from 10-K 8 pages Waiver February 18, 2024
12/34/56
EX-10.1
from 10-Q 83 pages Revenue Interest Purchase Agreement Dated as of May 12, 2023 Among Humacyte Global, Inc., as the Company, Humacyte, Inc., as Parent, the Purchasers From Time to Time Party Hereto and Hook SA LLC, as Purchaser Agent
12/34/56
EX-10.12
from 10-K 9 pages Executive Employment Agreement
12/34/56
EX-10.11
from 10-K 8 pages Executive Employment Agreement
12/34/56
EX-10.11.2
from 10-K 7 pages Executive Separation and Release Agreement
12/34/56
EX-10.7.6
from 10-K 3 pages Sixth Amendment to Exclusive Patent License Agreement
12/34/56
EX-10.8
from 8-K 6 pages Humacyte, Inc. Annual Bonus Plan
12/34/56
EX-10.5
from 8-K 14 pages Humacyte, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.4(1)
from 8-K 9 pages Stock Option Grant Notice Under the Humacyte, Inc. 2021 Long-Term Incentive Plan
12/34/56
EX-10.4
from 8-K 13 pages Humacyte, Inc. 2021 Long-Term Incentive Plan
12/34/56
EX-10.23
from S-4/A 10 pages Form of Indemnity Agreement
12/34/56
EX-10.26
from S-4/A 9 pages Exhibit 1 to Severance Agreement and Release Consulting Agreement
12/34/56
EX-10.25
from S-4/A 4 pages Severance Agreement and Release
12/34/56
EX-10.18.1
from S-4/A 9 pages Stock Option Grant Notice Under the Humacyte, Inc. 2021 Long-Term Incentive Plan
12/34/56